Cibenzoline: Difference between revisions
No edit summary |
m (Protected "Cibenzoline": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{chembox | {{chembox new | ||
| UNII_Ref = {{fdacite|correct|FDA}} | | UNII_Ref = {{fdacite|correct|FDA}} | ||
| UNII = Z7489237QT | | UNII = Z7489237QT | ||
|ImageFile= | |ImageFile=Cibenzoline Wiki Str.png | ||
|ImageSize=120px | |ImageSize=120px | ||
|IUPACName=2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1''H''-imidazole | |IUPACName=2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1''H''-imidazole | ||
| Line 37: | Line 37: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Cibenzoline''' (or '''cifenline''') is a Class Ia [[antiarrhythmic]]. | '''Cibenzoline''' (or '''cifenline''') is a Class Ia [[antiarrhythmic]]. | ||
Latest revision as of 19:05, 18 August 2015
|
WikiDoc Resources for Cibenzoline |
|
Articles |
|---|
|
Most recent articles on Cibenzoline Most cited articles on Cibenzoline |
|
Media |
|
Powerpoint slides on Cibenzoline |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Cibenzoline at Clinical Trials.gov Clinical Trials on Cibenzoline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cibenzoline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Cibenzoline Discussion groups on Cibenzoline Patient Handouts on Cibenzoline Directions to Hospitals Treating Cibenzoline Risk calculators and risk factors for Cibenzoline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cibenzoline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cibenzoline (or cifenline) is a Class Ia antiarrhythmic.